Biopharmaceutical Market
  • Published on 2023-10-06
    • Report Code: 1683
    • 170-350 pages

Biopharmaceutical Market

Sample request

Biopharmaceutical Market Size, Share, and Analysis, By Product Type (Purified Proteins, Recombinant Growth Factors, Recombinant Proteins, Recombinant Hormone, Synthetic Immunomodulatory, Monoclonal Antibodies, Vaccines, Other), By Service (Custom Testing / Customer Proprietary Testing, Laboratory Testing, Compendial, and Multi Compendial Laboratory Testing), By Raw Material Type (Active Pharmaceutical Ingredients (API), Formulation Excipients, Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support), By Application (Autoimmune Disorders, Metabolic Disorders, Oncology, Inflammatory and Infectious Diseases, Hormonal Disorders, Neurological Diseases, Cardiovascular Diseases, and Other) and Regional Forecasts, 2022-2032

Table Of Content

1. Executive Summary

1.1.Regional Market Share

1.2. Business Trends

1.3. Biopharmaceutical Market: COVID-19 Outbreak

1.4.Regional Trends

1.5. Segmentation Snapshot

2. Research Methodology

2.1. Research Objective

2.2.Research Approach

2.3.Data Sourcing and Methodology 

2.4. Primary Research

2.5. Secondary Research

2.5.1.Paid Sources

2.5.2. Public Sources

2.6.Market Size Estimation and Data Triangulation

3. Market Characteristics

3.1. Market Definition

3.2.Biopharmaceutical Market: COVID-19 Impact

3.3.Key Segmentations 

3.4. Key Developments

3.5. Allied Industry Data

4. Biopharmaceutical Market – Industry Insights

4.1.Industry Segmentation

4.2. COVID-19 overview on world economy

4.3. Industry ecosystem Channel analysis

4.4. Innovation & Sustainability

5. Macroeconomic Indicators

6. Recent Developments

7.Market Dynamics

7.1. Introduction

7.2.Growth Drivers

7.3.Market Opportunities

7.4. Market Restraints

7.5.Market Trends

8. Risk Analysis

9. Market Analysis

9.1. Porters Five Forces

9.2.PEST Analysis

9.2.1. Political 

9.2.2.Economic

9.2.3.Social

9.2.4.Technological

10. Biopharmaceutical Market

10.1.Overview

10.2. Historical Analysis (2016-2021)

10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast

11.Biopharmaceutical Market Size & Forecast 2022A-2032F

11.1.Overview

11.2. Key Findings

11.3. Market Segmentation

11.3.1.By Product Type

11.3.1.1. Purified Proteins

11.3.1.1.1. By Value (USD Million) 2022-2032F

11.3.1.1.2.Market Share (%) 2022-2032F

11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F

11.3.1.2.Recombinant Growth Factors

11.3.1.2.1.By Value (USD Million) 2022-2032F

11.3.1.2.2. Market Share (%) 2022-2032F

11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F

11.3.1.3.Recombinant Proteins

11.3.1.3.1.By Value (USD Million) 2022-2032F

11.3.1.3.2. Market Share (%) 2022-2032F

11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F

11.3.1.4.Recombinant Hormone

11.3.1.4.1.By Value (USD Million) 2022-2032F

11.3.1.4.2. Market Share (%) 2022-2032F

11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F

11.3.1.5.Synthetic Immunomodulatory

11.3.1.5.1.By Value (USD Million) 2022-2032F

11.3.1.5.2. Market Share (%) 2022-2032F

11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F

11.3.1.6.Monoclonal Antibodies

11.3.1.6.1.By Value (USD Million) 2022-2032F

11.3.1.6.2. Market Share (%) 2022-2032F

11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F

11.3.1.7.Vaccines

11.3.1.7.1.By Value (USD Million) 2022-2032F

11.3.1.7.2. Market Share (%) 2022-2032F

11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F

11.3.1.8.Other

11.3.1.8.1.By Value (USD Million) 2022-2032F

11.3.1.8.2. Market Share (%) 2022-2032F

11.3.1.8.3. Y-o-Y Growth (%) 2022-2032F

11.3.2. By Service

11.3.2.1.Custom Testing / Customer Proprietary Testing

11.3.2.1.1.By Value (USD Million) 2022-2032F

11.3.2.1.2. Market Share (%) 2022-2032F

11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F

11.3.2.2. Laboratory Testing

11.3.2.2.1. By Value (USD Million) 2022-2032F

11.3.2.2.2.Market Share (%) 2022-2032F

11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F

11.3.2.3. Compendial, and Multi Compendial Laboratory Testing

11.3.2.3.1. By Value (USD Million) 2022-2032F

11.3.2.3.2.Market Share (%) 2022-2032F

11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F

11.3.3. By Raw Material Type

11.3.3.1.Active Pharmaceutical Ingredients (API)

11.3.3.1.1.By Value (USD Million) 2022-2032F

11.3.3.1.2. Market Share (%) 2022-2032F

11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F

11.3.3.2. Formulation Excipients

11.3.3.2.1. By Value (USD Million) 2022-2032F

11.3.3.2.2.Market Share (%) 2022-2032F

11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F

11.3.3.3. Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support

11.3.3.3.1. By Value (USD Million) 2022-2032F

11.3.3.3.2.Market Share (%) 2022-2032F

11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F

11.3.4. By Application

11.3.4.1.Autoimmune Disorders

11.3.4.1.1.By Value (USD Million) 2022-2032F

11.3.4.1.2. Market Share (%) 2022-2032F

11.3.4.1.3. Y-o-Y Growth (%) 2022-2032F

11.3.4.2. Metabolic Disorders

11.3.4.2.1. By Value (USD Million) 2022-2032F

11.3.4.2.2.Market Share (%) 2022-2032F

11.3.4.2.3. Y-o-Y Growth (%) 2022-2032F

11.3.4.3. Oncology

11.3.4.3.1. By Value (USD Million) 2022-2032F

11.3.4.3.2. Market Share (%) 2022-2032F

11.3.4.3.3. Y-o-Y Growth (%) 2022-2032F

11.3.4.4. Inflammatory and Infectious Diseases

11.3.4.4.1.By Value (USD Million) 2022-2032F

11.3.4.4.2. Market Share (%) 2022-2032F

11.3.4.4.3. Y-o-Y Growth (%) 2022-2032F

11.3.4.5. Hormonal Disorders

11.3.4.5.1.By Value (USD Million) 2022-2032F

11.3.4.5.2. Market Share (%) 2022-2032F

11.3.4.5.3. Y-o-Y Growth (%) 2022-2032F

11.3.4.6. Neurological Diseases

11.3.4.6.1. By Value (USD Million) 2022-2032F

11.3.4.6.2.Market Share (%) 2022-2032F

11.3.4.6.3.Y-o-Y Growth (%) 2022-2032F

11.3.4.7. Cardiovascular Diseases

11.3.4.7.1. By Value (USD Million) 2022-2032F

11.3.4.7.2.Market Share (%) 2022-2032F

11.3.4.7.3.Y-o-Y Growth (%) 2022-2032F

11.3.4.8. Other

11.3.4.8.1.By Value (USD Million) 2022-2032F

11.3.4.8.2. Market Share (%) 2022-2032F

11.3.4.8.3. Y-o-Y Growth (%) 2022-2032F

12. North America Biopharmaceutical Market Size & Forecast 2022A-2032F

12.1. Overview

12.2. Key Findings

12.3. Market Segmentation

12.3.1. By Product Type

12.3.2.By Service

12.3.3.By Raw Material Type

12.3.4.By Application

12.4. Country

12.4.1.United States

12.4.2. Canada

13. Europe Biopharmaceutical Market Size & Forecast 2022A-2032F

13.1. Overview

13.2. Key Findings

13.3. Market Segmentation

13.3.1. By Product Type

13.3.2.By Service

13.3.3.By Raw Material Type

13.3.4.By Application

13.4. Country

13.4.1.Germany

13.4.2. United Kingdom

13.4.3. France

13.4.4. Italy

13.4.5. Spain

13.4.6. Russia

13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)

14. Asia Biopharmaceutical Market Size & Forecast 2022A-2032F

14.1.Overview

14.2. Key Findings

14.3. Market Segmentation

14.3.1. By Product Type

14.3.2.By Service

14.3.3.By Raw Material Type

14.3.4. By Application

14.4. Country

14.4.1.India

14.4.2. China

14.4.3. South Korea

14.4.4. Japan

14.4.5. Rest of APAC

15. Middle East and Africa Biopharmaceutical Market Size & Forecast 2022A-2032F

15.1.Overview

15.2. Key Findings

15.3. Market Segmentation

15.3.1. By Product Type

15.3.2.By Service

15.3.3.By Raw Material Type

15.3.4.By Application

15.4. Country

15.4.1.Israel

15.4.2. GCC

15.4.3. North Africa

15.4.4. South Africa

15.4.5. Rest of Middle East and Africa

16. Latin America Biopharmaceutical Market Size & Forecast 2022A-2032F

16.1. Overview

16.2. Key Findings

16.3. Market Segmentation

16.3.1. By Product Type

16.3.2.By Service

16.3.3.By Raw Material Type

16.3.4.By Application

16.4. Country

16.4.1. Mexico

16.4.2. Brazil

16.4.3. Rest of Latin America

17. Competitive Landscape

17.1. Company market share, 2021

17.2.Key player overview

17.3. Key stakeholders

18. Company Profiles 

18.1.Amgen Inc.

18.1.1.Company Overview

18.1.2.Financial Overview

18.1.3.Key Product; Analysis

18.1.4.Company Assessment

18.1.4.1.Product Portfolio

18.1.4.2. Key Clients

18.1.4.3. Market Share 

18.1.4.4. Recent News & Development (Last 3 Yrs.)

18.1.4.5. Executive Team

18.2. AstraZeneca

18.3. Johnson & Johnson Private Limited

18.4.Lilly

18.5. Pfizer Inc.

18.6. Sanofi

18.7. Abbott

18.8.Novartis AG

18.9. F. Hoffmann-La Roche Ltd.

18.10.Novo Nordisk A/S

18.11.bioMérieux

18.12.Merck & Co., Inc.

18.13.Bristol-Myers Squibb Company

18.14.GlaxoSmithKline Plc

18.15.Bayer AG

18.16. Biogen

18.17. Other Prominent Players

19. Appendix

20.Consultant Recommendation

Research Methodology

Primary Research

  • Fatpos Global’s dedicated primary research wing comprises a team of analysts adept at conducting and engaging in detailed primary interviews with key industry stakeholders across the entire value chain.
  • The primary research comprises formulation of a detailed discussion guides composed of questions pertaining to various data points essential developing an in-depth report.
  • The subsequent stages development of an exhaustive market participants, key opinion leaders, industry experts and executives, among others.
  • Manufacturers, distributors & suppliers, key End Users, industry experts, opinion leaders, and industry association members, among others compose the sample for the research study

Supply Side

  • R&D technicians and technologists
  • Procurement Managers
  • Physician If s/Specialist
  • Research Professors
  • Healthcare Providers
  • Consumers
  • Distributors & Channels
  • Service Provide

Demand Side

  • CEOs
  • Vice presidents
  • Marketing directors
  • RProduct Managers
  • Regional Sales and
  • Marketing Managers
  • Business Development
  • Plant Manage

Research Framework

    Objective of Research

  • The objective of the research is to provide a 360 holistic view on the market and bringing the insights that can help stakeholders identify the opportunities as well as challenges.
  • We have provided the market size in terms of value and volume of market with segmentation and offers in-depth commentary and accurate quantitative insights.
  • The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

    Primary Research

  • Fatpos Global’s dedicated primary research wing comprises a team of analyst adept at conducting and engaging in detailed primary interviews with key industry stakeholders across the entire value chain.
  • The primary research comprises formulation of a detailed discussion guides composed of questions pertaining to various data points essential developing an in-depth report.
  • The subsequent stages development of an exhaustive market participants, key opinion leaders, industry experts and executives, among others.
  • Manufacturers, distributors & suppliers, key End Users, industry experts, opinion leaders, and industry association members, among others compose the sample for the research study
  • Analysts compile the whole data from demand and supply-side perceptions

    Secondary Research

  • Data is gathered from various secondary databases.
  • Diligently tracking the secondary sources for closely monitoring the market trends and insights.
  • Analysts compile the whole data from demand and supply-side perceptions for the better outputs.

Data Sources

    Research Approach

  • Demand Estimation of each product across countries/regions summed from the total market
  • Variable analysis for demand forecasting
  • Demand estimation via analysing paid database, company financials either via annual report or database
  • Primary interviews for data revalidation and insights collection.
  • Used extensively for new product forecasting or analysing penetration level
  • Tool used invoices product flow & penetration models
  • Use of regression multi variate analysis for forecasting
  • Involve extensive use of paid and public database
  • Primary interviews & vendor-based primary research for variable impact analysis

Bottom-Up Approach

Top-Down Approach

To request a free sample copy of this report, please complete the form below.

Purchase Report

Select your license

$3199

Buy Now Add to cart

Compare all license features

Note: In case you require a hard copy, there will be an additional charge of $500.

Sample request

Read all reports

Sciatica Treatment Market
Sciatica Treatment Market

Sciatica Treatment Market Size, Share, and Analysis, By Type (Chronic Sciatica, Acute Sciatica), By Drug Class (Steroids, Non-Steroidal Anti-Inflammatory Drugs, Antidepressants, and Others), By Distribution Channel (Retail and Specialty Pharmacies, Hospital Pharmacies, Online Providers), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

$3199

Second-Hand Products Market
Second-Hand Products Market

Second-Hand Products Market Size, Share, and Analysis, By Product Type (Sporting Goods, Electronics, Clothing, Vehicles, Furniture, and Others), By End Use (Individual, Commercial), By Brand Type (Luxury Brands, Non-Luxury Brands), By Distribution Channel (Online, Offline) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034 

$3199

Peripheral Intravenous Catheters Market
Peripheral Intravenous Catheters Market

Peripheral Intravenous Catheters Market Size, Share, and Analysis, By Product Type (Short PIVC, Integrated/Closed PIVC), By Technology (Conventional PIVC, Safety PIVC), By End User (Hospitals, Ambulatory Surgical Centres, and Other End Users) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034

$3199

Connected Energy Market
Connected Energy Market

Connected Energy Market Size, Share, and Analysis, By Type (Smart Solar, Smart Grid, Digital Oilfields, and Home Energy Management Systems), By Application (Residential, Commercial, and Industrial), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

$3199

Renewable Energy Technology Market
Renewable Energy Technology Market

Renewable Energy Technology Market Size, Share, and Analysis, By Type (Hydroelectric Power, Wind Power, Solar Power, Geothermal Energy, and Bioenergy), By Application (Commercial, Residential, and Industrial), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

$3199

Poultry Market
Poultry Market

Poultry Market Size, Share, and Analysis, By Type (Chicken, Turkey, Duck, and Others), By Product Type (Fresh, Frozen, Ready-To-Cook, Ready-To-Eat, Others), By Nature (Organic, Conventional), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, Food Services, E-Commerce, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034

$3199

LNG and LPG Market
LNG and LPG Market

LNG and LPG Market Size, Share, and Analysis, By Type (Liquefied Petroleum Gas (LPG) and Liquefied Natural Gas (LNG)), By Application (Residential Heating, Transportation, Industrial, and Power Generation), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

$3199

LNG Carrier Market
LNG Carrier Market

LNG Carrier Market Size, Share, and Analysis, By Type (Membrane Type and Moss Type), By Capacity (Above 160,000 m3, 120,000-160,000 m3, and Under 120,000 m3), By Application (International Transportation and Domestic Transportation), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

$3199

LPG Carriers Market
LPG Carriers Market

LPG Carriers Market Size, Share, and Analysis, By Type (Total Cooling (Above 50000m³), Semi-Cold and Semi-Pressed (5000m³-50000m³), Full Pressure Type (Below 5000m³)), By Carrier Size (Small Gas Carriers (SGC), Medium Gas Carriers (MGC), Large Gas Carriers (LGC), and Very Large Gas Carriers (VLGC)), By Application (Leasing Company, and Shipowner), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

$3199

Ocean Freight Market
Ocean Freight Market

Ocean Freight Market Size, Share, and Analysis, By Type (Less than Container Load (LCL), Full Container Load (FCL), and Breakbulk Cargo), By Carrier Type (Tankers, Bulk Carriers, Containers, and Others), By Application (Manufacturing, Electronics, Agricultural, Automotive, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

$3199

Our Clients

We have been working with some Fortune 500+ clients

we use cookie for improve your experience

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy . By continuing to use this site, or closing this box, you consent to our use of cookies. More info .